Article info
PDFOriginal research
Implementing NGS-based BRCA tumour tissue testing in FFPE ovarian carcinoma specimens: hints from a real-life experience within the framework of expert recommendations
- Correspondence to Dr Valerio Gaetano Vellone, Department of Surgical and Diagnostic Sciences, University of Genoa, Genova 16126, Italy; valerio.vellone{at}unige.it
Citation
Implementing NGS-based BRCA tumour tissue testing in FFPE ovarian carcinoma specimens: hints from a real-life experience within the framework of expert recommendations
Publication history
- Received June 8, 2020
- Revised August 5, 2020
- Accepted August 6, 2020
- First published September 7, 2020.
Online issue publication
January 08, 2022
Article Versions
- Previous version (8 January 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.